Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic HypersomniaDisorders of Excessive Somnolence, Dyssomnias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Sleep Disorders, Intrinsic, idiopathic hypersomnia, nervous system disorder, psychiatric disorder, sleep-wake disorderActive, not recruitingPhase 22026-09-25NCT06843590

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Alkermes, Inc.11

48 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Alkermes Investigator SiteMiddletownUnited States1
Alkermes Investigator SiteMadisonUnited States1
Alkermes Investigator SiteKansas CityUnited States1
Alkermes Investigator SiteNamurBelgium1
Alkermes Investigator SiteAustinUnited States1
Alkermes Investigator SiteVeronaItaly1
Alkermes Investigator SiteMilanItaly1
Alkermes Investigator SiteDanvilleUnited States1
Alkermes Investigator SiteLansingUnited States1
Alkermes Investigator SiteBordeauxFrance1
Alkermes Investigator SiteSan FranciscoUnited States1
Alkermes Investigator SiteBarcelonaSpain1
Alkermes Investigator SiteSugarlandUnited States1
Alkermes Investigator SiteLos AngelesUnited States1
Alkermes Investigator SitePeoriaUnited States1
Alkermes Investigator SiteSugar LandUnited States1
Alkermes Investigator SiteStockbridgeUnited States1
Alkermes Investigator SitePhoenixUnited States2
Alkermes Investigator SiteMaconUnited States1
Alkermes Investigator SiteBrandonUnited States1
Alkermes Investigator SiteBolognaItaly1
Alkermes Investigator SiteDenverUnited States1
Alkermes Investigator SiteZwolleNetherlands1
Alkermes Investigator SiteCullmanUnited States1
Alkermes Investigator SiteColumbiaUnited States1